Thomas Trimarchi
CIK: 0002030813
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BridgeBio Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Aug 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct22.8K shares at avg. $79.86$1.8M - May 18, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct3.2K shares at avg. $65.95$211K - May 18, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct10.5K shares at avg. $64.82$678K - May 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct22.8K shares at avg. $66.13$1.5M - Mar 18, 2026BBIO
BridgeBio Pharma, Inc.
Award(A)Direct59K shares- - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct200 shares at avg. $75.38$15K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct13.4K shares at avg. $74.71$1.0M - Feb 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct18.8K shares at avg. $75.25$1.4M - Dec 12, 2025BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct13.8K shares at avg. $75.15$1.0M - Nov 17, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct7K shares at avg. $66.84$465K - Nov 17, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct10K shares at avg. $66.19$660K - Nov 16, 2025BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct21.3K shares at avg. $66.39$1.4M - Aug 21, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct42.2K shares at avg. $49.48$2.1M - Aug 18, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct2K shares at avg. $50.94$101K - Aug 18, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct15.4K shares at avg. $50.14$771K - Aug 16, 2025BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct21.3K shares at avg. $51.32$1.1M - May 16, 2025BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct21.3K shares at avg. $33.84$721K - Mar 19, 2025BBIO
BridgeBio Pharma, Inc.
Award(A)Direct109.1K shares- - Feb 16, 2025BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct13.8K shares at avg. $34.90$481K - Dec 10, 2024BBIO
BridgeBio Pharma, Inc.
Award(A)Direct50K shares- - Nov 16, 2024BBIO
BridgeBio Pharma, Inc.
Tax Payment(F)Direct17.9K shares at avg. $23.72$425K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 22,781 | $79.86 | $1,819,291 | Direct |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 3,195 | $65.95 | $210,712 | Direct |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 10,456 | $64.82 | $677,707 | Direct |
| May 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 22,781 | $66.13 | $1,506,508 | Direct |
| Mar 18, 2026 | BBIO BridgeBio Pharma, Inc. | Award(A) | 59,041 | - | $0 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 200 | $75.38 | $15,076 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 13,400 | $74.71 | $1,001,071 | Direct |
| Feb 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 18,819 | $75.25 | $1,416,130 | Direct |
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 13,826 | $75.15 | $1,039,024 | Direct |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 6,956 | $66.84 | $464,938 | Direct |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 9,978 | $66.19 | $660,467 | Direct |
| Nov 16, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 21,317 | $66.39 | $1,415,236 | Direct |
| Aug 21, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 42,237 | $49.48 | $2,090,081 | Direct |
| Aug 18, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 1,973 | $50.94 | $100,512 | Direct |
| Aug 18, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 15,380 | $50.14 | $771,210 | Direct |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 21,317 | $51.32 | $1,093,988 | Direct |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 21,317 | $33.84 | $721,367 | Direct |
| Mar 19, 2025 | BBIO BridgeBio Pharma, Inc. | Award(A) | 109,100 | - | - | Direct |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 13,782 | $34.90 | $480,992 | Direct |
| Dec 10, 2024 | BBIO BridgeBio Pharma, Inc. | Award(A) | 50,000 | - | $0 | Direct |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | Tax Payment(F) | 17,936 | $23.72 | $425,442 | Direct |
1-21 of 21 transactions
About Trimarchi Thomas
Trimarchi Thomas (SEC CIK 0002030813) files insider reports with the SEC as President and CFO of BridgeBio Pharma, Inc. (BBIO).
Signal8 holds 13 ownership filings by Trimarchi Thomas, all Form 4s, filed between Nov 19, 2024 and Aug 18, 2026. Those filings report 21 transactions, from Nov 16, 2024 to Aug 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Trimarchi Thomas's filings is in PALO ALTO, CA.
Recent filings by Trimarchi Thomas
- Aug 16, 2026: Tax withholding of BBIO shares (Form 4, code F).
- May 18, 2026: Open-market sales of BBIO shares (2 lines, Form 4, code S).
- May 16, 2026: Tax withholding of BBIO shares (Form 4, code F).
- Mar 18, 2026: Grant or award of BBIO shares (Form 4, code A).
- Feb 17, 2026: Open-market sales of BBIO shares (2 lines, Form 4, code S).
Other insiders filing for BridgeBio Pharma, Inc. (BBIO)
- Apuli Maricel, Chief Accounting Officer
- Kumar Neil, Chief Executive Officer
- Ellis Andrea, Director
- Cook Jennifer E., Director
- Valantine Hannah, Director
- Lo Andrew, Director